BiotechTube
Home/Molecure/Adam Gołębiowski, PhD, DSc
AG

Adam Gołębiowski, PhD, DSc

Chief Development Officer

Molecure

Therapeutic Areas

OncologyInflammatory Diseases

Molecure Pipeline

DrugIndicationPhase
OATD-01Idiopathic Pulmonary Fibrosis (IPF)Phase II
OATD-02Oncology (Solid Tumors)Phase I
RNA Platform ProgramsUndisclosed Oncology TargetsDiscovery
PPI Platform ProgramsUndisclosed Oncology & Immunology TargetsDiscovery

Leadership Team at Molecure

MS
Marcin Szumowski, PhD
Chief Executive Officer, President of the Management Board
MW
Michał Walczak, PhD
Chief Scientific Officer
KB
Krzysztof Brzózka, PhD
Chief Technology Officer
PR
Piotr Radziwon, PhD
Chief Business Officer
View full Molecure profile